|
private:asymchemlaboratoriestianjin
|
288555
|
May 22nd, 2019 12:00AM
|
Asymchem Group
|
1.4K
|
286.00
|
Open
|
Pharmaceuticals
|
May 22nd, 2019 10:43AM
|
May 22nd, 2019 10:43AM
|
Asymchem is a global CMC CDMO with USFDA inspected facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products and applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Asymchem was founded in 1995 and is headquartered in Tianjin, P. R. China with 3,250 employees.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem’s proven team of experienced process and engineering teams extends upon a >20 years track record.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
Open
|
Process R&D, Continuous Flow chemistry, Biocatalysis, Hydrogenation, CMC, API, Small Molecule, Validation, HPAPI, Commercial Manufacturing, CDMO, USFDA inspected, Development, Late Clinical Phase, CMO, cGMP, ICH Q7A, R&D, Kilo Scale, Pilot Plant
|
Open
|
600 Airport Blvd
|
Morrisville
|
NC
|
US
|
27560
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 17th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 16th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 15th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 14th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 13th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 12th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 11th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 10th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|
|
private:asymchemlaboratoriestianjin
|
288555
|
Feb 9th, 2018 12:00AM
|
Asymchem Group
|
868
|
201.00
|
Open
|
Pharmaceuticals
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Asymchem is an API CDMO with USFDA facilities in P.R. China. Core capabilities include process development and commercial manufacturing of late phase to launched products, applying innovative technologies as a sustainable means to reducing cost and meet increasing environmental restrictions. Founded in 1995, headquartered in Tianjin, P. R. China, total staff of 2000 personnel to date, USFDA and Australian TGA inspected facilities.
Asymchem's expertise lies in developing economical and environmentally feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by a fully track record proven team of experienced process and engineering team.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
|
|
|
|
|
|
|
|
|
|
Asymchem Laboratories (Tianjin)
|
|
Health Care Equipment & Services
|